Founders of Stenocare join directed issue
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on Dec 19, 2023. STENOCARE A/S (“Stenocare” or the “Company”) announced as per 11 December 2023 at 08.00 (CET) that the founders and executive team of Stenocare decided to exercise their TO1 warrants. Two participants will exercise their TO1 warrants. Two founders have, instead, decided to let their warrants lapse and